Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) Short Interest Update

Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) saw a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 700 shares, an increase of 40.0% from the March 15th total of 500 shares. Based on an average daily volume of 13,500 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.0% of the company’s shares are sold short.

Institutional Investors Weigh In On Tema Cardiovascular and Metabolics ETF

A hedge fund recently raised its stake in Tema Cardiovascular and Metabolics ETF stock. Sterling Investment Advisors Ltd. increased its holdings in shares of Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) by 5.7% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 167,703 shares of the company’s stock after purchasing an additional 9,008 shares during the quarter. Tema Cardiovascular and Metabolics ETF accounts for about 1.2% of Sterling Investment Advisors Ltd.’s investment portfolio, making the stock its 24th largest holding. Sterling Investment Advisors Ltd. owned approximately 7.29% of Tema Cardiovascular and Metabolics ETF worth $4,842,000 at the end of the most recent quarter.

Tema Cardiovascular and Metabolics ETF Stock Up 1.0 %

HRTS stock opened at $27.69 on Friday. Tema Cardiovascular and Metabolics ETF has a 52 week low of $25.32 and a 52 week high of $36.03. The company has a market cap of $53.72 million, a price-to-earnings ratio of 27.70 and a beta of 0.93. The business has a fifty day simple moving average of $29.28 and a 200-day simple moving average of $30.63.

About Tema Cardiovascular and Metabolics ETF

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.